美国FDA完全批准Keytruda用于MSI-H/dMMR实体瘤成人和儿童患者
0:50
bilibili爱医传递-生命之路
美国FDA完全批准Keytruda用于MSI-H/dMMR实体瘤成人和儿童患者
近日，美国FDA完全批准默沙东的抗PD-1单抗Keytruda(pembrolizumab，帕博利珠单抗)用于经FDA批准的检测方法确定的不可切除或转移性高度微卫星不稳定型(MSI-H)或错配修复缺陷型(dMMR)实体瘤成人和儿童患者。 这是首款获得FDA完全批准的与实体瘤类型无关 ...
已浏览 235 次2023年3月31日
Pembrolizumab Uses
Keytruda (pembrolizumab): Uses, How It Works, and Common Side Effects - Drugs.com
1:19
Keytruda (pembrolizumab): Uses, How It Works, and Common Side Effects - Drugs.com
YouTubeDrugs.com
已浏览 3903 次9 个月之前
Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
2:05
Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
YouTubeNEJM Group
已浏览 1.1万 次2017年3月16日
Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
2:13
Neoadjuvant Pembrolizumab for Lung Cancer | NEJM
YouTubeNEJM Group
已浏览 4207 次2023年8月10日
热门视频
Merck's Keytruda gets an upgrade
4:35
Merck's Keytruda gets an upgrade
Microsoft NewsCNBC
1 个月前
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
8:11
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
Microsoft NewsCNBC
1 个月前
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
8:11
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
CNBC
1 个月前
Pembrolizumab Side Effects
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
2:27
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
YouTubeNEJM Group
已浏览 2381 次11 个月之前
Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM
2:23
Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM
YouTubeNEJM Group
已浏览 3935 次2024年3月7日
Pembrolizumab Unveiling Its Mechanism and Research Applications with Biosimilars
7:58
Pembrolizumab Unveiling Its Mechanism and Research Applications with Biosimilars
YouTubeAssay Genie
已浏览 367 次9 个月之前